Shenzhen Yuce Neoantigen Technology Co., Ltd. ("YuceNeo") is a wholly-owned subsidiary of Shenzhen YuceBio Technology Co., Ltd. It relies on the international leading neoantigen predication technology platform, the largest Chinese tumor immunotherapy real-world data platform and the multi-omics research and translation platform centering on immune cycles to provide one-stop solution for the development of tumor immunotherapy drugs, including CDx development, central lab test, biomarker development, tumor immunotherapy data mining, neoantigen prediction and validation, and patient recruitment services.
We have 1500 square meters of modern medical laboratory space (including PCR, NGS, pathology and cell platforms, etc.) in Shenzhen Dapeng Biological Valley. The medical laboratory has CAP certification and ISO9001 on-site certification. A clinical biology analysis and experimental center that meets the GLP/GCP standards has been established, which can provide biological sample analysis services at all stages of clinic studies. We have a 3000 square meter GMP production workshop in Taizhou that meets the requirements of GSP management regulations.
Ph.D. in Medical Science, Chinese University of Hong Kong, and COP student of China Europe International Business School
Former Director of the Department of Gene Medicine Research and Head of Cancer Bioinformatics Team of BGI
Member of the International Cancer Genome Consortium (ICGC) and core member of the Chinese Cancer Genome Consortium (CCGC)
Published many academic papers as the co-first author on journals including Nature and Science;
In March 2017, Dr. Gao and many top oncologists in China jointly launched the "Ladder for Cancer Moonshot".
Ph.D in Internal Medicine, School of Medicine, Xi'an Jiaotong University
Former Head of Diagnostic Medicine and Business Development Department of Simcere
Head of Medical and Clinical Business Department, and Deputy General Manager of KingMed Diagnostics Group
Intermediate and senior management positions such as the Head of Respiratory Medicine Team at AstraZeneca
More than 10 years of experience in pharmaceutical and precision medicine industries
·Former BGI Senior Bioinformation Engineer
·Participated in the China Cancer Genome Project (CCGC), International Cancer
·Genome Program (ICGC), National 863 High-Tech Program Eesophageal Cancer
·Tumor Neoantigen Screening Alliance (TESLA), etc
·Postdoctoral fellow at the Center for Biomedical Engineering, Michigan State University
·CSC National Public Study Program Harvard Medical School-Harbin University of Technology
·Member of the American Society of Neurobiology and the World Society of Medical Imaging
Copyright©2021
Shenzhen yucebio Technology Co., Ltd. all rights reserved
Yueicp no.16128839